Page 2 - Long Term Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LYON, France, September 26, 2023--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its financial results for the period ended June 30, 2023 and provided a corporate update.

Where do Subaru Canada's dealer service departments rank with other car brands? They are dead last, according to a new study. Check out the best and worst here.

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...

Men with high level of cardiorespiratory fitness or those who do aerobic exercises may have a lower risk of developing specific types of cancer, says new study | Health

/PRNewswire/ -- Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™...